ConductScience.org, home

Paper42226306

Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.

Wu J and 9 others. Cancer Imaging, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma. Papers, record 42226306. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226306

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microstructure mapping with time-dependent diffusion MRI differentiates primary central nervous system lymphoma from glioblastoma.
PubMed
Journal
Cancer Imaging
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu JJun
2Lu JJue
3Zhang XXinli
4Guo XXiaotong
5Qin QQian
6Chen JJiaqi
7Zheng NNing
8Sun PPeng
9Gao XXuan
10Wang JJing

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Diffusion Magnetic Resonance ImagingMajor topic
LymphomaMajor topic
Brain NeoplasmsMajor topic
Central Nervous System NeoplasmsMajor topic
Humans
Female
Middle Aged
Male
Diagnosis, Differential
Adult
Aged

Source PubMed

Download CSV of topics

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124814181Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging.Radiology2014https://conductscience.org/library/papers/24814181PubMed
238946879Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma.Neurooncol Adv2024https://conductscience.org/library/papers/38946879PubMed
334051685Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.Eur J Radiol2021https://conductscience.org/library/papers/34051685PubMed
420677208Characterization of tissue structure at varying length scales using temporal diffusion spectroscopy.NMR Biomed2010https://conductscience.org/library/papers/20677208PubMed
535812103
Diagnostic Accuracy of the Diffusion-Weighted Imaging Method Used in Association With the Apparent Diffusion Coefficient for Differentiating Between Primary Central Nervous System Lymphoma and High-Grade Glioma: Systematic Review and Meta-Analysis.
Front Neurol2022https://conductscience.org/library/papers/35812103PubMed
621330399Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.AJNR Am J Neuroradiol2011https://conductscience.org/library/papers/21330399PubMed
717805551Diffuse glioma growth: a guerilla war.Acta Neuropathol2007https://conductscience.org/library/papers/17805551PubMed
826225937Comparison of Apparent Diffusion Coefficient and Intravoxel Incoherent Motion for Differentiating among Glioblastoma, Metastasis, and Lymphoma Focusing on Diffusion-Related Parameter.PLoS One2015https://conductscience.org/library/papers/26225937PubMed
932662130Primary Central Nervous System Lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning.J Magn Reson Imaging2021https://conductscience.org/library/papers/32662130PubMed
1027631626Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.PLoS One2016https://conductscience.org/library/papers/27631626PubMed
1135510125Multiparametric MR Imaging Features of Primary CNS Lymphomas.Front Surg2022https://conductscience.org/library/papers/35510125PubMed
1236617263Histological and molecular classifications of pediatric glioma with time-dependent diffusion MRI-based microstructural mapping.Neuro Oncol2023https://conductscience.org/library/papers/36617263PubMed
1329104150Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.World Neurosurg2018https://conductscience.org/library/papers/29104150PubMed
1426384329Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors.PLoS One2015https://conductscience.org/library/papers/26384329PubMed
1539371035CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021.Neuro Oncol2024https://conductscience.org/library/papers/39371035PubMed
1627330520A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research.J Chiropr Med2016https://conductscience.org/library/papers/27330520PubMed
1733890149Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques.Eur Radiol2021https://conductscience.org/library/papers/33890149PubMed
1830035121Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.Biomed Res Int2018https://conductscience.org/library/papers/30035121PubMed
1937171492Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.Eur Radiol2023https://conductscience.org/library/papers/37171492PubMed
2029867979Immune Microenvironment in Glioblastoma Subtypes.Front Immunol2018https://conductscience.org/library/papers/29867979PubMed

See all 44 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42226306

GET https://conductscience.org/api/papers/v1/42226306/references?page=2